About Heehyoung Lee
Form D filings for Calidi Biotherapeutics in 2023 list Heehyoung Lee as director.
Heehyoung Lee reports to the SEC as a director of 1 public company.
Heehyoung Lee first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Heehyoung Lee in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Heehyoung Lee works with at each company, as listed on that company's latest Form D.
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN
George Ng
Director